North America Contraceptives Market

Market Introduction

The North America Contraceptives Market is segmented into the US, Canada, and Mexico. The US held the largest share of the North American contraceptives market in 2020. The growth can be attributed to awareness among the population, prevention of unwanted pregnancies and increasing product developments by key players in the region. Also, rising awareness for sexually transmitted diseases is likely to favor market growth. In North America, the US holds a significant share in the contraceptives market. The growth of the market in the country is primarily driven by increasing awareness for birth control. As per the 2015–2017 National Survey of Family Growth data, in 2015–2017, around 64.9% (46.9 million) of the 72.2 million women aged between 15–49 years in the US were using contraception. It also mentioned the commonly used contraceptive methods were female sterilization (18.6%), oral contraceptive pill (12.6%), long-acting reversible contraceptives (LARCs) (10.3%), and male condom (8.7%). As per the survey female sterilization decreased and use of the pill increased with higher education. Further, also the growing prevalence of sexually transmitted diseases is increasing the demand for contraceptives. For instance, according to the Centers for Disease Control and Prevention (CDC), in 2018, one in five (68 million) people in the US have an STI (sexually transmitted infection) of which 26 million cases were new STIs in 2018. Increasing rate of unwanted pregnancies is the major factor driving the growth of the North America contraceptives market.

North America has been witnessing a growing number of COVID-19 cases since its outbreak. For instance, according to Worldometer, the number of cases increased to 30,521,774, with 555,314 deaths reported in the US as of March 22, 2021. The cases are also increasing in Mexico and Canada. In Mexico, the cases have reached 2,195,772, with 198,036 deaths. Similarly, in Canada, there are about 933,785 COVID cases, with 22,676 deaths reported so far.The pandemic is straining public health systems globally, interrupting and delaying many kinds of critical health care. A recent survey by the World Health Organization found that family planning and contraception are among the most frequently disrupted health services. 7 in 10 countries around the world are experiencing disruptions along with United States, Canada and Mexico. However, the COVID-19 pandemic does not disrupt the supply of and demand generation for condoms. Sexual relations may be transformed in the new context of the pandemic, but they have not stopped. While access to male and female condoms has been critical in the global response to reduce HIV, sexually transmitted infections (STIs), and unintended pregnancies over the past three decades, these gains can be lost if condoms are not included in the essential commodities that are freely available to populations during the lockdown of countries. This brief for country condom program managers and experts provides a summary of relevant actions to sustain supplies of male condoms, female condoms, and lubricants and to adjust approaches for condom promotion during the time of COVID-19. However, in the long run, market is expected to boost the demand, as IUDs centers now opening for patients for reproductive health other than COVID -19.

Market Overview and Dynamics

The contraceptives market in North America is expected to grow from US$ 10,859.29 million in 2021 to US$ 15,386.11 million by 2028; it is estimated to grow at a CAGR of 5.1% from 2021 to 2028. Sexually transmitted diseases (STDs) have a major impact on sexual and reproductive health worldwide. As per the WHO, more than 1 million sexually transmitted infections (STIs) are acquired every day worldwide. Each year, ~376 million new infections with chlamydia, gonorrhea, syphilis, and trichomoniasis are reported. Contraceptive methods alter the risk of acquiring STDs. For instance, spermicides have been reported to kill a wide range of bacteria and viruses, including HIV, in vitro; moreover, they have been reported to provide protection against gonorrhea, chlamydia, and pelvic inflammatory disease in vivo. Condoms and diaphragms also provide a certain level of protection from bacterial and viral infections.

Key Market Segments

The market for North America contraceptives market is segmented into product, end user, and distribution channel, and country. Based on product, the market is segmented condoms, intrauterine product (IUDs), vaginal rings, implants, patches, diaphragms, emergency contraceptives, sponges, and others. The condoms segment dominated the market in 2020 and intrauterine product (IUDs) segment is expected to be the fastest growing during the forecast period. Further, the condoms segment has been bifurcated into female condoms and male condoms. Similarly, intrauterine product (IUDs) is bifurcated into hormonal IUDs and copper IUDs. Based on end user, the market is segmented into home care, and hospitals and clinics. The home care segment dominated the market in 2020 and is expected to be the fastest growing during the forecast period. Based on distribution channel, the market is segmented into retail pharmacy, online pharmacy, and hospital pharmacy. The retail pharmacy segment dominated the market in 2020 and is expected to be the fastest growing during the forecast period.

Major Sources and Companies Listed

A few major primary and secondary sources referred to for preparing this report on the contraceptives market in North America are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Bayer AG; Church & Dwight, Inc.; CooperSurgical (Cooper Companies, Inc.); Mayer Laboratories, Inc.; Medicines360; Merck & Co., Inc.; and Prosan International B.V. among others.

Reasons to buy report

• To understand the North America contraceptives market landscape and identify market segments that are most likely to guarantee a strong return
• Stay ahead of the race by comprehending the ever-changing competitive landscape for North America contraceptives market
• Efficiently plan M&A and partnership deals in North America contraceptives market by identifying market segments with the most promising probable sales
• Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form North America contraceptives market
• Obtain market revenue forecast for market by various segments from 2021-2028 in North America region.

North America Contraceptives Market Segmentation

North America Contraceptives Market -By Product

• Condoms
  • Male Condoms
  • Female Condoms
• Intrauterine Product (IUDs)
  • Hormonal IUDs
  • Copper IUDs
• Vaginal Rings
• Implants
• Patches
• Diaphragms
• Emergency Contraceptives
• Sponges
• Others

North America Contraceptives Market -By End User

• Home Care
• Hospitals and Clinics

North America Contraceptives Market -By Distribution Channel

• Retail Pharmacy
• Online Pharmacy
• Hospital Pharmacy

North America Contraceptives Market -By Country

• US
• Canada
• Mexico

North America Contraceptives Market -Company Profiles

• Bayer AG
• Church & Dwight, Inc.
• CooperSurgical (Cooper Companies, Inc.)
• Mayer Laboratories, Inc.
• Medicines360
• Merck & Co., Inc.
• Prosan International B.V.

North America Contraceptives Market Strategic Insights

North America Contraceptives Market Segmentation Analysis

North America Contraceptives Market Report Highlights

North America Contraceptives Report Scope

North America Contraceptives Market Country and Regional Insights